Dominant Negative Actions of Human Prostacyclin Receptor Variant Through Dimerization: Implications for Cardiovascular Disease
Open Access
- 1 September 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 30 (9), 1802-1809
- https://doi.org/10.1161/ATVBAHA.110.208900
Abstract
Objective— Prostacyclin and thromboxane mediate opposing cardiovascular effects through their receptors, the prostacyclin receptor (IP) and thromboxane receptor (TP). Individuals heterozygous for an IP variant, IP R212C , displayed exaggerated loss of platelet IP responsiveness and accelerated cardiovascular disease. We examined association of IP R212C into homo- and heterodimeric receptor complexes and the impact on prostacyclin and thromboxane biology. Methods and Results— Dimerization of the IP, IP R212C , and TPα was examined by bioluminesence resonance energy transfer in transfected HEK293 cells. We observed an equal propensity for formation of IPIP homodimers and IPTPα heterodimers. Compared with the IP alone, IP R212C displayed reduced cAMP generation and increased endoplasmic reticulum localization but underwent normal homo- and heterodimerization. When the IP R212C and IP were coexpressed, a dominant negative action of the variant was evident with enhanced wild-type IP localization to the endoplasmic reticulum and reduced agonist-dependent signaling. Further, the TPα activation response, which was shifted from inositol phosphate to cAMP generation following IPTPα heterodimerization, was normalized when the TPα instead dimerized with IP R212C . Conclusion— IP R212C exerts a dominant action on the wild-type IP and TPα through dimerization. This likely contributes to accelerated cardiovascular disease in individuals carrying 1 copy of the variant allele.Keywords
This publication has 30 references indexed in Scilit:
- Heterotrimeric G proteins precouple with G protein-coupled receptors in living cellsProceedings of the National Academy of Sciences of the United States of America, 2005
- Oligomerization of the α and β isoforms of the thromboxane A2 receptor: Relevance to receptor signaling and endocytosisCellular Signalling, 2005
- Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturationTrends in Pharmacological Sciences, 2005
- Dimerization of the Human Receptors for Prostacyclin and Thromboxane Facilitates Thromboxane Receptor-mediated cAMP GenerationOnline Journal of Public Health Informatics, 2004
- Multiple Interactions between Transmembrane Helices Generate the Oligomeric α1b-AdrenoceptorMolecular Pharmacology, 2004
- Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface TargetingOnline Journal of Public Health Informatics, 2004
- High-Affinity Interactions between Human α1A-Adrenoceptor C-Terminal Splice Variants Produce Homo- and Heterodimers but Do Not Generate the α1L-AdrenoceptorMolecular Pharmacology, 2004
- Role of extracellular cysteine residues in dimerization/oligomerization of the human prostacyclin receptorEuropean Journal of Pharmacology, 2004
- D2 Dopamine Receptor Homodimerization Is Mediated by Multiple Sites of Interaction, Including an Intermolecular Interaction Involving Transmembrane Domain 4Biochemistry, 2003
- A novel PGD2 receptor expressed in eosinophilsProstaglandins, Leukotrienes & Essential Fatty Acids, 2003